CD4 and Parkinson disease: There were no significant differences in the T cell (CD3+) proportions, including CD4+ and CD8+ T cell subsets and NK cells (CD3−CD56+), between PD patients which were all CMV-seropositive and HD groups in our cohorts (Table 2).